These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 36170927)
21. Mechanisms of ketamine action as an antidepressant. Zanos P; Gould TD Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791 [TBL] [Abstract][Full Text] [Related]
22. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine. Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718 [TBL] [Abstract][Full Text] [Related]
23. The synergistic mechanism of action of Dajianzhong decoction in conjunction with ketamine in the treatment of depression. Li C; Zhang J; Liu H; Yuan H; Cai J; Fogaça MV; Zhang YW Biomed Pharmacother; 2023 Sep; 165():115137. PubMed ID: 37453197 [TBL] [Abstract][Full Text] [Related]
24. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109 [TBL] [Abstract][Full Text] [Related]
25. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine. Deyama S; Kondo M; Shimada S; Kaneda K Transl Psychiatry; 2022 May; 12(1):178. PubMed ID: 35577782 [TBL] [Abstract][Full Text] [Related]
27. Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants. Duman RS; Deyama S; Fogaça MV Eur J Neurosci; 2021 Jan; 53(1):126-139. PubMed ID: 31811669 [TBL] [Abstract][Full Text] [Related]
28. Matrine alleviates depressive-like behaviors via modulating microbiota-gut-brain axis in CUMS-induced mice. Zhang M; Li A; Yang Q; Li J; Zheng L; Wang G; Sun Y; Huang Y; Zhang M; Song Z; Liu L J Transl Med; 2023 Feb; 21(1):145. PubMed ID: 36829227 [TBL] [Abstract][Full Text] [Related]
29. Rapid and sustained restoration of astrocytic functions by ketamine in depression model mice. Ma X; Yang S; Zhang Z; Liu L; Shi W; Yang S; Li S; Cai X; Zhou Q Biochem Biophys Res Commun; 2022 Aug; 616():89-94. PubMed ID: 35653826 [TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor. Wei Y; Chang L; Hashimoto K Mol Psychiatry; 2022 Jan; 27(1):559-573. PubMed ID: 33963284 [TBL] [Abstract][Full Text] [Related]
31. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine. Monteggia LM; Gideons E; Kavalali ET Biol Psychiatry; 2013 Jun; 73(12):1199-203. PubMed ID: 23062356 [TBL] [Abstract][Full Text] [Related]
32. Repeated ( Jiang Y; Wang X; Chen J; Zhang Y; Hashimoto K; Yang JJ; Zhou Z Gut Microbes; 2024; 16(1):2310603. PubMed ID: 38332676 [TBL] [Abstract][Full Text] [Related]
33. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Akinfiresoye L; Tizabi Y Psychopharmacology (Berl); 2013 Nov; 230(2):291-8. PubMed ID: 23732839 [TBL] [Abstract][Full Text] [Related]
34. Gut microbiota mediated inflammation, neuroendocrine and neurotrophic functions involved in the antidepressant-like effects of diosgenin in chronic restraint stress. Cui JJ; Huang ZY; Xie YH; Wu JB; Xu GH; Li CF; Zhang MM; Yi LT J Affect Disord; 2023 Jan; 321():242-252. PubMed ID: 36349650 [TBL] [Abstract][Full Text] [Related]
35. Effect of ketamine combined with DHA on lipopolysaccharide-induced depression-like behavior in rats. Chang D; Zhao J; Zhang X; Lian H; Du X; Yuan R; Wen Y; Gao L Int Immunopharmacol; 2019 Oct; 75():105788. PubMed ID: 31377587 [TBL] [Abstract][Full Text] [Related]
36. Ketamine - A New Antidepressant Drug with Anti-Inflammatory Properties. Jóźwiak-Bębenista M; Sokołowska P; Wiktorowska-Owczarek A; Kowalczyk E; Sienkiewicz M J Pharmacol Exp Ther; 2024 Jan; 388(1):134-144. PubMed ID: 37977808 [TBL] [Abstract][Full Text] [Related]
37. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772 [TBL] [Abstract][Full Text] [Related]
38. Potential link between antidepressant-like effects of ketamine and promotion of adult neurogenesis in the ventral hippocampus of mice. Yamada J; Jinno S Neuropharmacology; 2019 Nov; 158():107710. PubMed ID: 31310776 [TBL] [Abstract][Full Text] [Related]
39. BDNF/CREB signaling pathway contribution in depression pathogenesis: A survey on the non-pharmacological therapeutic opportunities for gut microbiota dysbiosis. Matin S; Dadkhah M Brain Res Bull; 2024 Feb; 207():110882. PubMed ID: 38244808 [TBL] [Abstract][Full Text] [Related]
40. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test. Wang X; Yang Y; Zhou X; Wu J; Li J; Jiang X; Qu Q; Ou C; Liu L; Zhou S Psychiatry Res; 2011 Jan; 185(1-2):248-53. PubMed ID: 20580983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]